GELAD chemotherapy with sandwiched radiotherapy for patients with newly diagnosed stage IE/IIE natural killer/T‐cell lymphoma: a prospective multicentre study-Reference-Cited by-同舟云学术

GELAD chemotherapy with sandwiched radiotherapy for patients with newly diagnosed stage IE/IIE natural killer/T‐cell lymphoma: a prospective multicentre study

Published:2021-11-21 Issue:4 Volume:196 Page:939-946
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Zhu Yang¹,Tian Shu²,Xu Lan³,Ma Yujie¹,Zhang Wenhao¹,Wang Lifeng⁴,Jin Lina⁵,Liu Chuanxu¹,Zhu Chuanying⁶,Li Zhichao¹,Hao Siguo¹,Zhong Hua³,Ding Hao²,Tao Rong¹^ORCID

Affiliation:

1. Department of Hematology Xinhua Hospital Shanghai Jiao Tong University School of Medicine ShanghaiChina

2. Department of Radiation Oncology Eye Ear Nose and Throat Hospital Fudan University ShanghaiChina

3. Department of Hematology Renji Hospital Shanghai Jiao Tong University School of Medicine ShanghaiChina

4. Department of Pathology Xinhua Hospital Shanghai Jiao Tong University School of Medicine ShanghaiChina

5. Department of Hematology Dongfang Hospital Tongji University ShanghaiChina

6. Department of Oncology Xinhua Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

Funder

Shanghai Hospital Development Center

Science and Technology Commission of Shanghai Municipality

Shanghai Municipal Education Commission

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17960

Reference41 articles.

1. Distribution of lymphoid neoplasms in Northwest China: Analysis of 3244 cases according to WHO classification in a single institution

2. Distribution of Lymphoid Neoplasms in China

3. Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution

4. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma

5. Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of pegaspargase, etoposide, gemcitabine (PEG) followed by involved-field radiation therapy in early-stage extranodal natural killer/T-cell lymphoma;Hematology;2024-09-13

2. Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma;Signal Transduction and Targeted Therapy;2024-03-06

3. GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis;Science Bulletin;2023-11

4. Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma;iScience;2023-08

5. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?;Frontiers in Oncology;2023-07-17